REGULATIONS FOR BLOOD and BLOOD PRODUCTS JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.

Slides:



Advertisements
Similar presentations
FDA QS reg/CLIA Comparison: Overview
Advertisements

CBER Whole Blood and Blood Components Diane K. Hall Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
REGULATIONS for SUPPLIES, EQUIPMENT, REAGENTS and TESTING JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.
License Supplements under 21 CFR
Inspection of Collection Facilities. Collection Standards: C1 General Apply to all CTPs collected from living donors Facility must apply with all applicable.
1 ISBT 128 Industry Standard and Implementation Process Overview.
Maintaining a Safe and Adequate Supply of Donated Blood During a Severe Emergency Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs, OBRR,
FABB HOT TOPICS Current Issues in Blood Banking Ron Jackson Director, Compliance Branch FDA FLORIDA DISTRICT June 7, 2013.
Blood Donor Written Statement of Understanding
Regulatory Challenges in the Cell Preparation Facility Adrian Gee Center for Cell & Gene Therapy Regulatory Challenges in the Cell Preparation Facility.
CBER 510(k) Challenges and Strategies Susan Finneran Director of Clinical and Regulatory Affairs.
CBER 1 Blood Establishment Computer Software (BECS) Michael Gorman, BA, MT(ASCP)SBB Consumer Safety Officer, CBER, OBRR, DBA September 15, 2009.
CBER Whole Blood and Blood Component Labeling Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
CBER 1 Normal Source Plasma Donor Program Rosia E. Nesbitt, BS, SBB(ASCP), CQA(ASQ) Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
The Safety of the Blood Supply
Americas Technical Advisory Group ICCBBA ISBT 128 Blood Product Labeling – A Hospital Perspective Americas Technical Advisory Group ICCBBA.
Competency/Training and CLIA
QUALITY ASSURANCE IN BLOOD BANKING
CBER Irradiated Blood Components Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
CBER Cooperative Manufacturing Arrangements (Contractors) Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 15, 2009.
Draft Guidance for Industry Minimally Manipulated, Unrelated, Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution in Patients.
CBER Pre-License and Pre-Approval Inspections
Good Manufacturing Practices for Blood Establishments
CBER Blood Establishment Registration and Product Listing Jan O’Brien Blood Registration Coordinator DBA, OBRR, CBER September 15, 2009.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
FDA Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components.
FDA and American Red Cross Blood Supply Safety & Protection Geoff Withnell, CQE, CQA, CQMgr System Design Engineer American Red Cross.
WWLC Standard Operating Procedures Presented by Frank Hall, Laboratory Certification Coordinator.
Ensuring Product Quality in Gene Transfer Clinical Trials
CBER Review Considerations on Source Plasma Vaccination Programs Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Bridging the Gap Between Biologics & Compliance. Grant Funds Provided by Continuing Nursing Education Credit Provided by.
CBER 1 Establishment Submissions Rosia E. Nesbitt, BS, SBB(ASCP), CQA(ASQ) Consumer Safety Officer CBER, OBRR, DBA September 15, 2009.
RAISING THE BAR Meeting CSA Guidelines And Preparing for Health Canada
CBER Red Blood Cell Immunization Programs Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Tutorial for Transfusion Medicine Residents Regulatory Processes and the Blood Service.
Regulatory Big Brother of Biotechnology. Role of FDA FDA was designed to promote and protect the public’s health Food and Drug Cosmetic Act first passed.
Apheresis Blood Components
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
IN THE NAME OF GOD Quality Assurance and Blood Bank S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO)
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
CBER’s Blood Safety Team Blood Products Advisory Committee 01 May 2008 Jonathan C. Goldsmith, MD Office of Blood Research and Review.
CBER 1 Review Considerations on Additional Centers under an Approved License Rosia E. Nesbitt, BS, SBB(ASCP), CQA(ASQ) Consumer Safety Officer CBER, OBRR,
CBER Alternative Procedures “Variances” Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 15, 2009.
Awesome Variances “First break all the rules” Carolyn Te Young & Jed Gorlin ABC 7/04.
12 th Annual FDA & the Changing Paradigm for Blood Regulation – 01/16/2009 – Las Vegas, NV – Gilliam B. Conley 1 FDA perspective on “Where are we? Where.
QSR and GLP What exactly are these?.
Overview of FDA's Regulatory Framework for PET Drugs
CBER 1 Disease Associated Antibody Donor Program Rosia E. Nesbitt, BS, SBB(ASCP), CQA(ASQ) Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
QUALITY ASSURANCE & QUALITY CONTROL OF BLOOD COMPONENTS
Expectations for Facilities & cGMPs Biological Response Modifiers Advisory Committee Meeting October 9, 2003 Nicholas Obiri, Ph.D. CBER.
Comparability Protocols Lore Fields MT(ASCP)SBB Consumer Safety Officer DBA/OBRR/CBER September 16, 2009.
CBER Source Plasma Labeling Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Minimizing the Risks of TSE Agents in Human Tissues Melissa A. Greenwald, M.D. Division of Human Tissues Office of Cellular, Tissue and Gene Therapies;
CBER Common Problems on Source Plasma Inspections Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
FDA Perspective on the PASSPORT Study FDA Perspective on the PASSPORT Study Salim A. Haddad, M.D. Laboratory of Cellular Hematology Division of Hematology.
Licensure of Apheresis Blood Products August 15, 2007 Lister Hill Auditorium, NIH Bethesda, MD.
LPHS Blood Drive May 18, Blood. What is it? There are four main components of blood. Red Blood Cells White Blood Cells Platelets Plasma.
Human Specimen Repositories Requirements of 21 CFR Parts 50 & 56 PRIM & R May 5, 2004 Sally A. Hojvat, Ph.D. Director of Microbiology Devices Office of.
Allogeneic donor selection and blood collection by Mohammed Abu-basha 1.
Created by S. Purcell Storage and Record Keeping Requirements for Transfusable Blood Components.
Presented by Karen Dosanjh Quality Director Blood Systems
נמטוציטים משושנת ים Eli. S Lec. No.2.
Storage and Record Keeping Requirements for Transfusable Blood Components Created by S. Purcell.
Introduction to Immunohematology
Fish Farming & Food Regulations
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
SUPPORTING THE RUN Blood Transfusion Services Role in Assisting with Patient Care during Massive Transfusion Events.
Human Blood Types Exist because there are three proteins that can be found on human red blood cells: A protein B protein Rh Factor [if it’s present, the.
Storage and Record Keeping Requirements for Transfusible Blood Components Presenter: S. Purcell.
Blood Transfusions Blood products (p.731) PRBC’s Frozen PRBC’s
Presentation transcript:

REGULATIONS FOR BLOOD and BLOOD PRODUCTS JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1

 DONOR and RECIPIENT SAFETY  FROM COLLECTION TO TRANSFUSION  PRODUCTS  TESTING  RECORDS  STAFF 2

 HEALTH and HUMAN SERVICES  FDCA  FDA  SAFETY  QUALITY  PURITY  POTENCY 3

 CENTER for BIOLOGICS EVALUATION and RESEARCH ( CBER)  LICENSING for BIOLOGICS  BLOOD AS A BIOLOGIC 4

 BLA  BIOLOGICS LICENSE APPLICATION  ELA- ESTABLISHMENT  PLA- PRODUCT 5

 GUIDANCE DOCUMENTS  CODE OF FEDERAL REGUALTIONS  TITLE 42CFR  493 6

 CODE OF FEDERAL REGUALTIONS  TITLE 21CFR 

 cGMP (606)  ORGANIZATION & PERSONNEL  FACILITY  EQUIPMENT  PRODUCTION & PROCESS CONTROLS  FINISHED PRODUCT CONTROLS  LAB CONTROLS  RECORDS & REPORTS 8

 ESTABLISHMENT REGISTRATION  PRODUCT LISTING  DOMESTIC  FOREIGN  EXEMPTIONS: 9

 BIOLOGIC PRODUCT STANDARDS  BLOOD REQUIREMENTS- GENERAL 10

 ADDITIONAL REQUIREMENTS for BLOOD BY PRODUCT TYPE  WHOLE BLOOD  RED CELLS  FFP  PLATELETS 11

 DONORS  DONOR SUITABILITY  HEALTH & HISTORY  COLLECTION  METHODS  TECHNIQUES 12

 PRODUCTS:  MODIFYING  PROCESSING  LABELING 13

 PRODUCT QC  STORING  SHIPPING 14

 TESTING STANDARDS  SAMPLES  REAGENTS  TEST METHODS 15

 VARIANCES  EXAMPLE:  THAWED FFP EXPIRATION  21 CFR (m)(3  6 HOURS POST THAW  24 HOURS POST THAW 16

 THE COALITION FOR BLOOD SAFETY AABB AMERICA’S BLOOD CENTERS AMERICAN RED CROSS ARMED SERVICES BLOOD PROGRAM 17

 BLA EXAMPLES:  RED BLOOD CELLS  PLATELETS 18

19